Abstract A119: ALX2004, a novel topoisomerase I inhibitor antibody-drug conjugate for the treatment of EGFR-expressing solid tumors
Year: 2025
Type: conference-abstract
Source: Molecular Cancer Therapeutics
Authors: Janica Wong, Ana Monegal-Granados, Hanako Daino-Laizure, Jia-Xu Li, Jessica L. Morgan, Sarah Bolton, Andrew Olson, Yin Labson, Connie Lu, Sen Xu, Venita De Almedia, Hadi Falahatpisheh, Peter Strop, Jaume Pons, Marija Vrljic
Institution: ALX Oncology Inc. (United States)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4415444458
Cites:
Cited by:
Related to: